Medi Assist Healthcare Services Ltd Stock Falls to 52-Week Low of Rs.372

1 hour ago
share
Share Via
Medi Assist Healthcare Services Ltd has declined to a fresh 52-week low of Rs.372, marking a significant downturn in the stock’s performance amid broader market pressures and company-specific financial results. The stock’s recent trajectory highlights a period of sustained weakness, reflecting a combination of valuation concerns and quarterly earnings trends.
Medi Assist Healthcare Services Ltd Stock Falls to 52-Week Low of Rs.372

Stock Price Movement and Market Context

On 27 Feb 2026, Medi Assist Healthcare Services Ltd’s share price touched an intraday low of Rs.372, representing a 3.41% decline on the day and a 3.14% drop compared to the previous close. This new low also marks the stock’s all-time lowest price point. The stock has underperformed its sector by 2.99% on the same day and has been on a downward trend for seven consecutive trading sessions, resulting in a cumulative loss of 10.36% over this period.

The broader market context saw the Sensex open flat but subsequently decline by 534.32 points, or 0.68%, closing at 81,686.16. While the Sensex itself is trading below its 50-day moving average, it remains above its 200-day moving average, indicating some underlying market volatility. In contrast, Medi Assist’s shares are trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — underscoring the stock’s current bearish momentum.

Financial Performance and Valuation Metrics

The company’s recent quarterly results have contributed to the stock’s subdued performance. For the quarter ending December 2025, Medi Assist reported a Profit Before Tax (PBT) of Rs.15.11 crores, which is 23.9% lower than the average of the previous four quarters. Net Profit After Tax (PAT) also declined sharply by 45.4% to Rs.11.11 crores compared to the prior four-quarter average. Additionally, interest expenses reached a quarterly high of Rs.8.39 crores, exerting further pressure on profitability.

Despite these setbacks, the company maintains a Return on Equity (ROE) of 14.05%, reflecting a degree of fundamental strength over the longer term. However, the stock’s valuation appears expensive relative to its fundamentals, trading at a Price to Book Value ratio of 5. This premium valuation contrasts with the stock’s recent underperformance and declining earnings, contributing to the negative sentiment among market participants.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Comparative Performance and Market Position

Over the past year, Medi Assist Healthcare Services Ltd has delivered a negative return of 19.15%, significantly lagging behind the Sensex’s positive 9.48% gain during the same period. The stock’s 52-week high was Rs.594.40, indicating a substantial decline of approximately 37.5% from that peak to the current 52-week low.

This underperformance is not isolated to the past year alone; the stock has consistently lagged behind the BSE500 index in each of the last three annual periods. Such a trend highlights persistent challenges in maintaining competitive returns relative to the broader market and sector peers.

Sector and Industry Context

Medi Assist operates within the insurance industry, a sector that has experienced mixed performance amid fluctuating market conditions. While some indices, such as the S&P BSE Oil & Gas, reached new 52-week highs on the same day, the insurance sector has faced headwinds that have weighed on stock prices, including Medi Assist’s. The company’s market capitalisation grade stands at 3, reflecting a mid-tier valuation within its sector.

The company’s Mojo Score, a proprietary metric assessing stock quality and momentum, currently stands at 23.0 with a Mojo Grade of Strong Sell, an upgrade from the previous Sell rating issued on 2 Dec 2025. This grading reflects the stock’s deteriorating financial metrics and price performance, signalling caution in the current market environment.

Medi Assist Healthcare Services Ltd or something better? Our SwitchER feature analyzes this small-cap Insurance stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Long-Term Fundamentals and Valuation Considerations

Despite the recent price decline and earnings contraction, Medi Assist Healthcare Services Ltd exhibits a degree of long-term fundamental strength. The company’s average ROE of 14.05% indicates efficient capital utilisation relative to many peers in the insurance sector. However, the stock’s current valuation at a Price to Book ratio of 5 suggests that the market is pricing in expectations that may not align with recent earnings trends.

Interest expenses reaching a quarterly peak of Rs.8.39 crores have also contributed to margin pressures, impacting net profitability. The combination of elevated financing costs and declining profit margins has weighed on investor sentiment, reflected in the stock’s sustained downward movement.

Summary of Key Metrics

To summarise, Medi Assist Healthcare Services Ltd’s key financial and market metrics as of 27 Feb 2026 are:

  • New 52-week low price: Rs.372
  • One-year return: -19.15%
  • Sensex one-year return: +9.48%
  • Quarterly PBT: Rs.15.11 crores (-23.9% vs previous 4Q average)
  • Quarterly PAT: Rs.11.11 crores (-45.4% vs previous 4Q average)
  • Quarterly interest expense: Rs.8.39 crores (highest recorded)
  • Return on Equity (ROE): 14.05%
  • Price to Book Value: 5
  • Mojo Score: 23.0
  • Mojo Grade: Strong Sell (upgraded from Sell on 2 Dec 2025)

The stock’s performance and valuation metrics reflect a challenging period for Medi Assist Healthcare Services Ltd, with the share price retreating to levels not seen in over a year. The combination of declining quarterly profits, rising interest costs, and a premium valuation multiple has contributed to the current market stance.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News